Inhaled tranexamic acid as a treatment option in nonmassive hemoptysis: a randomized controlled trial
Background Hemoptysis is a potentially life-threatening condition with variable etiology and severity. Tranexamic acid (TXA), an antifibrinolytic agent, has demonstrated efficacy in bleeding control. Nebulized TXA offers targeted pulmonary delivery with reduced systemic exposure, but clinical eviden...
Enregistré dans:
| Auteurs principaux: | , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Wolters Kluwer Medknow Publications
2026-04-01
|
| Collection: | Egyptian Journal of Chest Disease and Tuberculosis |
| Sujets: | |
| Accès en ligne: | https://doi.org/10.4103/ecdt.ecdt_62_25 |
| Tags: |
Pas de tags, Soyez le premier à ajouter un tag!
|